Luminex, Merck to develop Alzheimer's diagnostic device

03/14/2013 | American City Business Journals · Fox Business

Luminex and Merck & Co. have entered a partnership to develop a diagnostic device for Alzheimer's disease that will be used to screen patients for a clinical trial of Merck's drug candidate MK-8931. The device will assess levels of two potential disease biomarkers in cerebrospinal fluid samples from patients who demonstrate mild cognitive impairment.

View Full Article in:

American City Business Journals · Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID